Fund Holdings — Checkpoint Capital L.P.

Total Portfolio Value
$278.65M
Total Bought
$13.94M
Total Sold
$35.55M
Net Transaction
-$21.61M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
SEPTERNA INC(SEPN)0100,300+100,30002,4100.86%+2,410
CRINETICS PHARMACEUTICALS IN(CRNX)040,230+40,23001,4610.52%+1,461
CYTOKINETICS INC(CYTK)166,823180,000+13,17710,60011,8644.26%+1,264
TREVI THERAPEUTICS INC(TRVI)050,000+50,00005970.21%+597
RHYTHM PHARMACEUTICALS INC(RYTM)992,2001,227,200+235,000106,205106,73038.30%+524
REVOLUTION MEDICINES INC(RVMD)370,000262,539-107,46129,47125,5329.16%-3,939
ARGENX SE(ARGX)142,000153,000+11,000119,415111,72840.10%-7,687
CORCEPT THERAPEUTICS INC(CORT)401,3950-401,39513,9690—-13,969
DISC MEDICINE INC(IRON)452,992286,661-166,33135,97218,3296.58%-17,643
Page 1 of 1
Checkpoint Capital L.P. — 13F Holdings — Q1 2026 | TickerTrail